Benjamin Haynor
Stock Analyst at Lake Street
(0.97)
# 3,915
Out of 5,182 analysts
14
Total ratings
30.77%
Success rate
-8.65%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FEMY Femasys | Initiates: Buy | $1.5 | $0.42 | +253.44% | 1 | Mar 3, 2026 | |
| PROF Profound Medical | Maintains: Buy | $11 → $12 | $7.15 | +67.83% | 2 | Jan 7, 2026 | |
| SRTA Strata Critical Medical | Assumes: Buy | $8 | $4.52 | +76.99% | 1 | Dec 2, 2025 | |
| INFU InfuSystem Holdings | Assumes: Buy | $15 | $10.79 | +39.02% | 1 | Sep 22, 2025 | |
| ELMD Electromed | Assumes: Buy | $36 | $25.40 | +41.73% | 1 | Aug 27, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $64.08 | -70.35% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $10.06 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $1,400 | $7.46 | +18,666.76% | 1 | Aug 29, 2017 |
Femasys
Mar 3, 2026
Initiates: Buy
Price Target: $1.5
Current: $0.42
Upside: +253.44%
Profound Medical
Jan 7, 2026
Maintains: Buy
Price Target: $11 → $12
Current: $7.15
Upside: +67.83%
Strata Critical Medical
Dec 2, 2025
Assumes: Buy
Price Target: $8
Current: $4.52
Upside: +76.99%
InfuSystem Holdings
Sep 22, 2025
Assumes: Buy
Price Target: $15
Current: $10.79
Upside: +39.02%
Electromed
Aug 27, 2025
Assumes: Buy
Price Target: $36
Current: $25.40
Upside: +41.73%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $64.08
Upside: -70.35%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $10.06
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $1,400
Current: $7.46
Upside: +18,666.76%